• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Basic research progress in microenergy medicine

Basic research progress in microenergy medicine

来源 :泌尿生殖肿瘤华夏医学论坛2016暨长城国际泌尿男科转化医学论坛2016 | 被引量 : 0次 | 上传用户：superdog22
【摘 要】
：
In the last decade,the convergence of life sciences,physical sciences,and engineering has brought a host of opportunities and innovations for biomedical informatics and health care in microenergy medi
【作 者】
：
Zhongcheng Xin 
【机 构】
：
Andrology Center, Peking University First Hospital, Peking University,Beijing 100034, China
【出 处】
：
泌尿生殖肿瘤华夏医学论坛2016暨长城国际泌尿男科转化医学论坛2016
【发表日期】
：
2016年8期
【关键词】
：
microenergy medicine LESWT LIPUS magnetic field 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　In the last decade,the convergence of life sciences,physical sciences,and engineering has brought a host of opportunities and innovations for biomedical informatics and health care in microenergy medicine,and it is called the third revolution in the field of life science research.
其他文献
大黄素通过自噬途径对顺铂致NRK-52E细胞损害的保护及其机制研究
会议
心肾综合征患者行RRT起始时机与终止时机的观察性研究
研究目的：肾脏替代治疗(RRT)的起始时机与终止时机目前尚无定论，不恰当的开始或结束均会增加患者的并发症、住院时间和费用，甚至可能影响预后。心肾综合征的RRT治疗常兼顾肾功能和心功能，起始时机和终止时机可能与其他人群不同。本研究观察心肾综合征患者行RRT起始时机与终止时机。
会议
心肾综合征肾脏替代治疗(RRT)起始时机与终止时机
Analysis of vascular access of maintenance hemodialysis patients: a single center study
Introduction: There are more than 2,000,000 dialysis patients all over the world.These patients experience high mortality and morbidity and poor health-related quality of life.Vascular access is calle
会议
maintenance hemodialysisvascular accessAVFs
Fibrinogen adsorption in maintenance hemodialysis patient with Diabetic foot syndrome: A case report
Introduction: Small ulcers decrease the quality of life significantly in patients with diabeticfoot syndrome.The major element in the causation of ulceration is a disturbance of venous blood flow and
会议
maintenance hemodialysisdiabetic foot sydromeimmune adsorptionfibrinogen abso
Long-term outcomes of a novel therapeutic procedure for persistent or recurrent hemospermia by trans
Background: To assess the long-term follow-up outcomes of a novel diagnostic and therapeutic procedure for persistent or recurrent hemospermia by transurethral seminal vesiculoscopy.
会议
Hematospermiaseminal vesiculoscopyvesiculitisseminal calculusejaculatory duc
Sunitinib affects autophagy and apoptosis via regulation of glycolysis in renal cell carcinoma cells
Background: Renal cell carcinoma (RCC) is resistant to regular chemotherapy and radiation.Sunitinib,which targeted to VEGF receptor and other signal pathways,has been proved effective for prolonged ca
会议
Autophagyapoptosisrenal cell carcinoma (RCC)
The expression and function of coiled-coil domain-containing protein 34 in human bladder carcinoma
Background: Urothelial carcinoma of the bladder is a major cause of morbidity and mortality worldwide.Although localized bladder carcinomas could be managed by surgical resection,the recurrence and pr
会议
Coiled-coil domain-containing protein (CCDC)bladder carcinomatherapeutic targe
Brachytherapy for localized prostate cancer
Background: To evaluate the security and effect of brachytherapy for localized prostate cancer.Methods: Forty five patients with T1-T2 prostate cancer were treated with real-time transperineal ultraso
会议
Brachytherapyprostatecancer
Transurethral PlasmaKinetic enucleation of prostate versus transurethral PlasmaKinetic resection of
Background: To compare the efficacy and safety of transurethral PlasmaKinetic enucleation of prostate (PKEP) versus transurethral PlasmaKinetic resection of prostate (PKRP) for benign prostate hyperpl
会议
Benign prostate hyperplasiatransurethral PlasmaKinetic enucleation of prostate
The study on the diagnostic value of f/tPSA to the prostate cancer with tPSA greater than 10 ng/mL
Background: To investigate the differential value of the percentage of free to total prostate specific antigen (f/tPSA) in the diagnosis of prostate cancer (PCa) and benign prostatic hyperplasia (BPH)
会议
Prostate cancer (PCa)benign prostatic hyperplasia (BPH)prostate specific antig